Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 AlteredExpression phenotype LHGDN Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation. 12165290 2002
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 GeneticVariation phenotype LHGDN A high TAFI level (75th or higher percentile in thrombosis patients) was associated with a 2-fold higher risk for recurrence compared with lower levels. 14739223 2004
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.310 Biomarker phenotype LHGDN Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. 17706955 2007
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.310 Biomarker phenotype CTD_human C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. 16931792 2006
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.300 Biomarker phenotype CTD_human Among patients treated with clopidogrel for percutaneous coronary intervention, carriage of even 1 reduced-function CYP2C19 allele appears to be associated with a significantly increased risk of major adverse cardiovascular events, particularly stent thrombosis. 20978260 2010
Entrez Id: 1577
Gene Symbol: CYP3A5
CYP3A5
0.300 Biomarker phenotype CTD_human Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. 16754899 2006
Entrez Id: 1634
Gene Symbol: DCN
DCN
0.010 Biomarker phenotype LHGDN Collectively, these data demonstrate that decorin can regulate fibrin organization and reveal a novel mechanism by which extracellular matrix components can participate in hemostasis, thrombosis, and wound repair. 17046817 2006
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.010 AlteredExpression phenotype LHGDN For the first time, we show a strong association between endoglin and EGR-1, increased collagen and SMCs expression, decreased levels of intraplaque thrombosis, and a stable plaque phenotype. 19074480 2009
Entrez Id: 2022
Gene Symbol: ENG
ENG
0.010 AlteredExpression phenotype LHGDN For the first time, we show a strong association between endoglin and EGR-1, increased collagen and SMCs expression, decreased levels of intraplaque thrombosis, and a stable plaque phenotype. 19074480 2009
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.300 Biomarker phenotype CTD_human Thrombotic complications in three hemodialysis patients with heparin-induced thrombocytopenia type I. 14979412 2004
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.300 Biomarker phenotype CTD_human Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration. 25013951 2014
Entrez Id: 2159
Gene Symbol: F10
F10
0.300 Biomarker phenotype CTD_human Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates. 1279834 1992
Entrez Id: 2160
Gene Symbol: F11
F11
0.010 Biomarker phenotype LHGDN Factor XI in haemostasis and thrombosis: past, present and future. 17597996 2007
Entrez Id: 2162
Gene Symbol: F13A1
F13A1
0.010 GeneticVariation phenotype LHGDN Mutations in clotting factors and inflammatory bowel disease. 17156138 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype LHGDN However, a prothrombin 20210 defect should be considered in the differential diagnosis of patients with unexplained thrombosis. 17342369 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype CTD_human Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin? 17245631 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. 16283309 2006
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN A single-base change (G to A) at position 20210 in the 3' untranslated region of the prothrombin gene is associated with increased plasma levels of prothrombin and might therefore increase the risk for thrombosis. 12865818 2003
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN Group 1: A total of 377 children with thrombosis were analyzed during 7 years between January 1997 and 2004 and screened for prothrombin G20210A mutation. 16020118 2005
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Therapeutic phenotype RGD Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. 17293494 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype LHGDN Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. 17911197 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN The G20210A prothrombin gene, factor V Leiden, and MTHFR C677T mutations have been identified as predisposing genetic factors for thrombosis. 15958894 2005
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN The results indicate that FV Leiden prevalence is quite high and coexistence of FV Leiden with other hereditary causes of thrombosis such as prothrombin G20210A mutation and MTHFR enzyme defect is not rare in healthy population of Aegean region of Turkey. 17456626 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN A 10-year-old boy with basilar artery thrombosis who was heterozygous for prothrombin G20210A mutation is described. 17621506 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype RGD Hematological and morphological investigation of thrombogenic mechanisms in the lungs of phenylhydrazine-treated rats. 22402172 2013